Abstract:Overview of the SATB1‐MIR22HG‐GBA‐GluCer pathway. The senescence regulator SATB1 acts as a negative regulator of MIR22HG expression. Decreased SATB1 levels lead to increased MIR22HG expression. Following nuclear processing, miR‐22‐3p targets GBA mRNA, reducing its transcription. This results in reduced GCase activity and the consequent accumulation of its substrate GluCer, a cerebroside that impairs mitochondrial and lysosomal function. GluCer accumulation leads to elevated ROS production and increased Cdkn1a (p21), Cdkn2a (p16) and S100A9 expression, ultimately driving cellular senescence. Importantly, the genes SATB1, MIR22HG, and GBA (red stars) are associated with Parkinson's disease. During aging, SATB1 and GBA levels decrease (red hourglasses), while MIR22HG, GluCer, p21/p16, and ROS levels increase (green hourglasses), rendering DA neurons more vulnerable. Idiopathic Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, which is associated with neuroinflammation and reactive gliosis. The underlying cause of PD and the concurrent neuroinflammation are not well understood. In this study, we utilize human and murine neuronal lines, stem cell‐derived dopaminergic neurons, and mice to demonstrate that three previously identified genetic risk factors for PD, namely SATB1, MIR22HG, and GBA, are components of a single gene regulatory pathway. Our findings indicate that dysregulation of this pathway leads to the upregulation of glucocerebrosides (GluCer), which triggers a cellular senescence‐like phenotype in dopaminergic neurons. Specifically, we discovered that downregulation of the transcriptional repressor SATB1 results in the derepression of the microRNA miR‐22‐3p, leading to decreased GBA expression and subsequent accumulation of GluCer. Furthermore, our results demonstrate that an increase in GluCer alone is sufficient to impair lysosomal and mitochondrial function, thereby inducing cellular senescence. Dysregulation of the SATB1‐MIR22‐GBA pathway, observed in both PD patients and normal aging, leads to lysosomal and mitochondrial dysfunction due to the GluCer accumulation, ultimately resulting in a cellular senescence‐like phenotype in dopaminergic neurons. Therefore, our study highlights a novel pathway involving three genetic risk factors for PD and provides a potential mechanism for the senescence‐induced neuroinflammation and reactive gliosis observed in both PD and normal aging.

Glucosylceramide accumulation in microglia triggers STING-dependent neuroinflammation and neurodegeneration in mice

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease

Mitochondrial DNA Leakage and cGas/STING Pathway in Microglia: Crosstalk Between Neuroinflammation and Neurodegeneration

Microglial cGAS-STING signaling underlies glaucoma pathogenesis

Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation

The SATB1‐MIR22‐GBA axis mediates glucocerebroside accumulation inducing a cellular senescence‐like phenotype in dopaminergic neurons

A Multifaceted Evaluation of Microgliosis and Differential Cellular Dysregulation of Mammalian Target of Rapamycin Signaling in Neuronopathic Gaucher Disease

Linking Gba1 E326K mutation to microglia activation and mild age-dependent dopaminergic Neurodegeneration

cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases

cGAS-STING signalling regulates microglial chemotaxis in genome instability

Novel Insights into Parkin-Mediated Mitochondrial Dysfunction and "Mito-Inflammation" in α-Synuclein Toxicity. The Role of the cGAS-STING Signalling Pathway

Microglial cGAS deletion protects against amyloid-β induced Alzheimer's disease pathogenesis

Inhibition of microglial β-glucocerebrosidase hampers the microglia-mediated antioxidant and protective response in neurons

Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease

GHS-R1a deficiency protects against lipopolysaccharide-induced spatial memory impairment in mice

Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders

The cytosolic DNA‐sensing cGAS–STING pathway in neurodegenerative diseases

Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism

Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice

Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications

cGAS Mediates the Inflammatory Responses of Human Microglial Cells to Genotoxic DNA Damage